Press & Statements

CSRXP: GSK’S FLOVENT SCHEME DESIGNED TO SIDESTEP ACCOUNTABILITY FOR EGREGIOUS PRICE HIKES

Jan 5, 2024

Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to Read More

CSRXP: BIG PHARMA RINGS IN 2024 WITH EGREGIOUS PRICE HIKES ON HUNDREDS OF BRAND NAME PRESCRIPTION DRUGS

Jan 2, 2024

Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to Read More

CSRXP: BIG PHARMA DOUBLES DOWN ON EGREGIOUS PRICE HIKES OUTPACING INFLATION

Dec 14, 2023

Administration Announces Drug Makers Increased Prices Faster Than Rate of Read More

FACT SHEET: BIG PHARMA BRINGS INSULIN PRICE-GOUGING PLAYBOOK TO BLOCKBUSTER WEIGHT LOSS DRUGS

Dec 13, 2023

Big Pharma Eyeing Egregious Price Tags, Aggressive Marketing to Push GLP-1s Read More

CSRXP APPLAUDS FTC CRACKDOWN ON BIG PHARMA’S FLAGRANT ABUSE OF THE PATENT SYSTEM

Nov 7, 2023

Commission Targets More Than 100 Patents on Brand Name Products Listed in the Read More

FACT SHEET: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS, TAXPAYERS AND THE U.S. HEALTH CARE SYSTEM BILLIONS OF DOLLARS

Sep 21, 2023

Big Pharma’s Anti-Competitive Tactics Are The Root Cause of Out-of-Control Read More

CSRXP: BIG PHARMA MAKES EGREGIOUS VACCINE PRICES HIKES OFFICIAL

Sep 14, 2023

Pfizer and Moderna Raise Prices on Vaccines After Years of Taxpayer Read More

CSRxP: Weight Loss Drugs the Latest Target for Big Pharma’s Price-Gouging of American Patients

Aug 24, 2023

Analysis Finds Brand Name Drug Makers Setting U.S. Prices for Obesity Read More

CSRXP: BIG PHARMA INCREASES PRICES ON MORE THAN 100 BRAND NAME DRUGS IN LATEST PRICE HIKING BINGE

Jul 18, 2023

Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to Read More